The Patent Finder

Axiogenesis AG

Also on record
Records under this name other than patents Axiogenesis AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Axiogenesis AG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,318,488Assay for drug discovery based on in vitro differentiated cells
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,321,997Tissue modeling in embryonic stem (ES) cell system
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,945,840Non-invasive, in vitro functional tissue assay systems
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,835,433Non-invasive, in vitro functional tissue assay systems
Formerly held
Term ended
Term ended May 6, 2026 · USPTO record
Term endedTerm ended May 6, 2026USPTO record
US 9,726,662Assay for drug discovery based on in vitro differentiated cells
Formerly held
Term ended
Ended no later than May 11, 2025 · USPTO record
Term endedEnded no later than May 11, 2025USPTO record
US 8,148,152Method for the preparation of embryoid bodies (EBs) and uses thereof
Formerly held
Term ended
Term ended Feb 9, 2025 · USPTO record
Term endedTerm ended Feb 9, 2025USPTO record
US 7,105,344Fluorescent proteins as cell-type specific reporters
Term ended
Term ended Apr 10, 2019 · USPTO record
Term endedTerm ended Apr 10, 2019USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited